This Friday/Saturday, the EURLSSG (European Restless Legs Syndrome Study Group) will be holding its annual meeting. I took a quick look at their agenda, which you can view here:
eurlssg.org/downloads/dec-2024/Agenda_annual_meeting_2024.pdf
Two sessions caught my eye:
- Treatment of restless legs syndrome with Sativex
- USA-RLS-Guidelines –versus European views. Shall EURLSSG endorse the USA-Recommendations?
The second session seems particularly interesting, possibly discussing the shift away from Dopamine Agonists as first-line treatments(?).
I don’t have any additional details, but I thought this might be of interest to some of you